Enliven Therapeutics, Inc.
ELVN
Revenue
0.00
0.000.00%
-Assets
325.76M
▲20.33M▲6.66%
3 Months ChangeLiabilities
15.92M
▼-1.11M▼-6.53%
3 Months ChangeFree Cash Flow
-23.38M
▼-2.51M▼-12.00%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-13
Form 10-Q
ID: 0000950170-24-096239
2024-08-13
Form 8-K
ID: 0000950170-24-096204
2024-06-18
Form 8-K
ID: 0001193125-24-163507
2024-05-14
Form 10-Q
ID: 0000950170-24-059573
2024-05-14
Form 8-K
ID: 0000950170-24-059544
2024-04-11
Form 8-K
ID: 0001193125-24-092522
2024-04-09
Form 8-K
ID: 0001193125-24-090821
2024-03-19
Form 8-K
ID: 0001193125-24-070839
2024-03-14
Form 8-K
ID: 0000950170-24-031482
2023-11-09
Form 10-Q
ID: 0000950170-23-062080